Brivaracetam
9 NDCs across 1 manufacturer|0 Generic,9 Brand
Brivaracetam is used to treat seizures, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 12, 2016, and the first generic was approved Jun 9, 2022. FDA's Orange Book lists 38 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $220 million on Brivaracetam across 137,000 claims for 15,000 beneficiaries.
Brivaracetam is available as 9 NDCs from 1 manufacturer (0 generic, 9 brand), with NADAC prices from $23.99 to $24.07 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
0G / 9B
Manufacturers
1
competing in market
Price Spread
$23.99 – $24.07
per EA, 8 of 9 NDCs
7d Activity
avg -0.0% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
UCB, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing BRIVARACETAM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BRIVIACT 50 MG TABLET | $24.0744 per EA | -0.02% |
BRIVIACT 50 MG TABLET | $24.0744 per EA | -0.02% |
BRIVIACT 100 MG TABLET | $24.0698 per EA | -0.03% |
BRIVIACT 100 MG TABLET | $24.0698 per EA | -0.03% |
BRIVIACT 25 MG TABLET | $24.0660 per EA | — |
BRIVIACT 25 MG TABLET | $24.0660 per EA | — |
BRIVIACT 75 MG TABLET | $24.0580 per EA | +0.04% |
BRIVIACT 10 MG TABLET | $23.9864 per EA | — |
BRIVIACT 10 MG/ML ORAL SOLN | $4.8099 per ML | 0.00% |
Frequently Asked Questions
What is Brivaracetam used to treat?
Brivaracetam is used to treat seizures, per the National Library of Medicine's MED-RT classification.
When did Brivaracetam become available as a generic?
FDA approved the first generic Brivaracetam (ANDA) on Jun 9, 2022. The Orange Book currently lists 38 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Brivaracetam?
In 2024, Medicare Part D spent $220 million on Brivaracetam across 137,000 claims for 15,000 beneficiaries.
How many Brivaracetam products are on the market?
The Brivaracetam drug market contains 9 NDCs from 1 manufacturer — 0 generic and 9 brand products.
What is the price range for Brivaracetam?
NADAC reference prices for Brivaracetam range from $23.9864 to $24.0744 per EA — a 0% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Brivaracetam?
1 manufacturer lists Brivaracetam in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (9).
How has the price of Brivaracetam changed recently?
Over the past 7 days, 1 Brivaracetam NDC rose and 4 fell, with a market-wide average change of -0.0%.